Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Moderna Inc.

    NASDAQ: MRNA · Real-Time Price · USD
    27.47
    1.35 (5.17%)
    At close: Jun 06, 2025, 3:59 PM
    27.42
    -0.18%
    After-hours: Jun 06, 2025, 05:58 PM EDT

    Moderna Statistics

    Share Statistics

    Moderna has 386.74M shares outstanding. The number of shares has increased by 0.67% in one year.

    Shares Outstanding

    n/a
    		 386.74M

    Shares Change (YoY)

    n/a
    		 0.67%

    Shares Change (QoQ)

    n/a
    		 0.26%

    Owned by Institutions (%)

    n/a
    		 72.06%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 4,447

    FTD / Avg. Volume

    n/a
    		 0.04%

    Short Selling Information

    The latest short interest is 67.27M, so 17.4% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 67.27M

    Short % of Shares Out

    n/a
    		 17.4%

    Short % of Float

    n/a
    		 24.16%

    Short Ratio (days to cover)

    n/a
    		 5.77

    Valuation Ratios

    The PE ratio is -4.48 and the forward PE ratio is -3.51. Moderna's PEG ratio is 0.18.

    PE Ratio

    n/a
    		 -4.48

    Forward PE

    n/a
    		 -3.51

    PS Ratio

    n/a
    		 4.93

    Forward PS

    n/a
    		 1.5

    PB Ratio

    n/a
    		 1.46

    P/FCF Ratio

    n/a
    		 -3.94

    PEG Ratio

    n/a
    		 0.18
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Moderna.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 3.67, with a Debt / Equity ratio of 0.07.

    Current Ratio

    n/a
    		 3.67

    Quick Ratio

    n/a
    		 3.62

    Debt / Equity

    n/a
    		 0.07

    Debt / EBITDA

    n/a
    		 -0.22

    Debt / FCF

    n/a
    		 -0.18

    Interest Coverage

    n/a
    		 -164.38

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $557,931.03

    Profits Per Employee

    n/a
    		 $-613,965.52

    Employee Count

    n/a
    		 5,800

    Asset Turnover

    n/a
    		 0.23

    Inventory Turnover

    n/a
    		 12.51

    Taxes

    Income Tax

    n/a
    		 -46M

    Effective Tax Rate

    n/a
    		 1.28%

    Stock Price Statistics

    The stock price has increased by -81.81% in the last 52 weeks. The beta is 1.86, so Moderna's price volatility has been higher than the market average.

    Beta

    n/a
    		 1.86

    52-Week Price Change

    n/a
    		 -81.81%

    50-Day Moving Average

    n/a
    		 26.44

    200-Day Moving Average

    n/a
    		 42.74

    Relative Strength Index (RSI)

    n/a
    		 53.5

    Average Volume (20 Days)

    n/a
    		 10,937,573

    Income Statement

    In the last 12 months, Moderna had revenue of 3.24B and earned -3.56B in profits. Earnings per share was -9.27.

    Revenue

    n/a
    		 3.24B

    Gross Profit

    n/a
    		 1.77B

    Operating Income

    n/a
    		 -3.94B

    Net Income

    n/a
    		 -3.56B

    EBITDA

    n/a
    		 -3.39B

    EBIT

    n/a
    		 -3.58B

    Earnings Per Share (EPS)

    n/a
    		 -9.27
    Full Income Statement

    Balance Sheet

    The company has 1.93B in cash and 747M in debt, giving a net cash position of 1.18B.

    Cash & Cash Equivalents

    n/a
    		 1.93B

    Total Debt

    n/a
    		 747M

    Net Cash

    n/a
    		 1.18B

    Retained Earnings

    n/a
    		 10.04B

    Total Assets

    n/a
    		 12.7B

    Working Capital

    n/a
    		 5.16B
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -3B and capital expenditures -1.05B, giving a free cash flow of -4.05B.

    Operating Cash Flow

    n/a
    		 -3B

    Capital Expenditures

    n/a
    		 -1.05B

    Free Cash Flow

    n/a
    		 -4.05B

    FCF Per Share

    n/a
    		 -10.56
    Full Cash Flow Statement

    Margins

    Gross margin is 54.76%, with operating and profit margins of -121.91% and -110.04%.

    Gross Margin

    n/a
    		 54.76%

    Operating Margin

    n/a
    		 -121.91%

    Pretax Margin

    n/a
    		 -111.46%

    Profit Margin

    n/a
    		 -110.04%

    EBITDA Margin

    n/a
    		 -104.88%

    EBIT Margin

    n/a
    		 -121.91%

    FCF Margin

    n/a
    		 -125.31%

    Dividends & Yields

    MRNA does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for MRNA is $45.5, which is 65.6% higher than the current price. The consensus rating is "Hold".

    Price Target

    n/a
    		 $45.5

    Price Target Difference

    n/a
    		 65.6%

    Analyst Consensus

    n/a
    		 Hold

    Analyst Count

    n/a
    		 19
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 3.23

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist